Verapamil Hydrochloride

ANDA 70856, held by Watson Labs. Verapamil Hydrochloride.

As of Nov 15, 2026, ANDA 70856 (Verapamil Hydrochloride), held by Watson Labs, was first approved by FDA on Sep 23, 1986, with 11 approved supplements and 0 published complete response letters.

First approved: Sep 23, 1986
Supplements approved: 11
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 12 submissions below

Date	Submission	Status	Documents
Sep 23, 1986	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Verapamil Hydrochloride120MG · tablet;oral	Verapamil Hydrochloride	Discontinued

All 12 submissions, including labeling and manufacturing supplements


Aug 5, 1998	Supplement 15Labeling	Approved	None posted
Jun 4, 1993	Supplement 14Manufacturing	Approved	None posted
Jun 15, 1992	Supplement 13Labeling	Approved	None posted
Aug 7, 1991	Supplement 10Manufacturing	Approved	None posted
Mar 18, 1991	Supplement 12Labeling	Approved	None posted
Jan 28, 1991	Supplement 11Manufacturing	Approved	None posted
May 14, 1990	Supplement 9Labeling	Approved	None posted
Nov 7, 1988	Supplement 7Manufacturing	Approved	None posted
Nov 7, 1988	Supplement 6Manufacturing	Approved	None posted
Feb 20, 1987	Supplement 2Manufacturing	Approved	None posted
Feb 20, 1987	Supplement 1Manufacturing	Approved	None posted
Sep 23, 1986	Original application	Approved	None posted

Identifiers

Application: ANDA 70856
Drugs@FDA: Overview at FDA
Company: Watson Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters